This federal Project Grant award from the National Institute of Mental Health's (NIMH) Mental Health Research Grants program (CFDA 93.242) provides $831,180 in funding to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to advance precision psychiatry research.
The project, titled "PSYCHEMERGE: Advancing Precision Psychiatry," aims to develop generalizable and bias-aware algorithms for early detection and treatment matching in psychiatric disorders. Key objectives include creating a nationwide federated platform for collaborative algorithm development, integrating genomic and clinical data to discover novel biology, evaluating clinical applications such as differential diagnosis and treatment response prediction, and assessing the feasibility and utility of precision psychiatry tools.
The award will support MGH's work in partnership with a subrecipient, Harvard T.H. Chan School of Public Health, which will contribute expertise in federated and transfer learning to build an efficient multi-site collaborative infrastructure. The project period runs from September 1, 2024 to May 31, 2029.
Generated 3/18/25, 3:30 AM